Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(9 sites)
United States
University of Alabama at Birmingham, Birmingham, Alabama Cornell Medical Center, New York, New York University of North Carolina Chapel Hill, Morrisville, North Carolina Ohio State University, Columbus, Ohio University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania Dallas Nephrology Associates, Dallas, Texas University of Texas, Galveston, Texas University of Washington, Seattle, Washington University of Wisconsin, Madison, Wisconsin